Multiple Sclerosis Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Rev Neurosci. 2012 Jan 26;23(2):145-52. doi: 10.1515/revneuro-2011-068.
Oligodendrocyte injury and inflammatory demyelination are key pathological abnormalities of multiple sclerosis (MS), and its animal model, i.e., the experimental autoimmune encephalomyelitis (EAE). Traditionally, they are viewed as destructive processes secondary to a dysregulated autoimmune reaction. New evidence emerged over the last decade indicating that oligodendrocytes are not merely immune targets but rather active participants in the neuroimmune network and, in fact, can regulate the events leading to inflammatory demyelination. In this review, we are discussing the role of interferon regulatory factor 1 (IRF-1) as a master transcription factor orchestrating oligodendrocyte injury and inflammatory demyelination in MS and EAE. We are also discussing the significance of IRF-1 signaling in the induction of oligodendrocyte pyroptosis, a Caspase 1-dependent pro-inflammatory cell death, as a disease-enhancing mechanism. Finally, we are drawing attention to IRF-1 as a potential therapeutic target in MS and to the importance of investigating other oligodendrocyte-dependent disease mechanisms.
少突胶质细胞损伤和炎症性脱髓鞘是多发性硬化症(MS)及其动物模型,即实验性自身免疫性脑脊髓炎(EAE)的关键病理异常。传统上,它们被视为失调的自身免疫反应的继发破坏性过程。过去十年中出现的新证据表明,少突胶质细胞不仅是免疫靶标,而且是神经免疫网络的活跃参与者,实际上可以调节导致炎症性脱髓鞘的事件。在这篇综述中,我们讨论了干扰素调节因子 1(IRF-1)作为协调 MS 和 EAE 中少突胶质细胞损伤和炎症性脱髓鞘的主转录因子的作用。我们还讨论了 IRF-1 信号在诱导少突胶质细胞细胞焦亡(一种 Caspase 1 依赖性促炎细胞死亡)中的意义,这是一种增强疾病的机制。最后,我们提请注意 IRF-1 作为 MS 的潜在治疗靶点,并强调研究其他依赖少突胶质细胞的疾病机制的重要性。